CARA COOK: Open Payments
NPI 1679556336 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 71 payments from 15 companies in 2025. Trend: 2023 $1,655 · 2024 $1,029 · 2025 $1,149
Food & beverage: $1,149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $216 |
| PFIZER INC. | 8 | $131 |
| Lilly USA, LLC | 13 | $128 |
| Galderma Laboratories, L.P. | 1 | $128 |
| Novo Nordisk Inc | 6 | $97 |
| Abbott Laboratories | 5 | $90 |
| GlaxoSmithKline, LLC. | 5 | $86 |
| Corcept Therapeutics | 2 | $86 |
| Phathom Pharmaceuticals, Inc. | 4 | $73 |
| Inspire Medical Systems, Inc. | 1 | $29 |
Products named: MOUNJARO, ELIQUIS, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, Korlym, QULIPTA, VOQUEZNA, UBRELVY.
Industry payments across TX — which companies pay providers there.
